SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astec Lifesciences informs about press release

24 Apr 2025 Evaluate
Astec Lifesciences has informed that it enclosed copies of the newspaper publication of the Audited Financial Results for the Quarter and Financial Year ended 31st March, 2025 (as approved by the Board of Directors at its Meeting held on Wednesday, 23rd April, 2025, upon recommendation of the Audit Committee), published by the Company today, on Thursday, 24th April, 2025 in Business Standard (in English language) and Mumbai Lakshdeep (in Marathi language). The newspaper advertisements may also be accessed on the website of the Company (www.godrejastec.com).

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences Share Price

634.90 -24.80 (-3.76%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 643.85
PI Industries 2911.30
Bayer CropScience 4892.75
Sharda Cropchem 1042.95
Sumitomo Chemical 422.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×